Chahrazad Cherifi
Impact in
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
-
- Inflammatory mediators and NSAID effects
Papers in
-
- Osteoarthritis Treatment and Mechanisms 5
- Spondyloarthritis Studies and Treatments 1
-
- Complement system in diseases 1
- Immunotherapy and Immune Responses 1
- Co-authors
- Martine Esther Cohen-Solal (7 shared papers)Eric Haÿ (6 shared papers)Pascal Richette (4 shared papers)Hang‐Korng Ea (4 shared papers)Augustin Latourte (5 shared papers)Jérémy Maillet (2 shared papers)Wafa Bouaziz (2 shared papers)Thomas Funck‐Brentano (2 shared papers)
- Journals
- Osteoarthritis and Cartilage (4 papers)Annals of the Rheumatic Diseases (3 papers)Bone (1 paper)International Journal of Molecular Sciences (1 paper)Advanced Materials Interfaces (1 paper)
- Partner nations
- FranceBelgiumNetherlands
In The Last Decade
Chahrazad Cherifi
11 papers receiving 492 citations
Chahrazad Cherifi's Hit Papers
Peers
Comparison fields: 5 of 67
- Rheumatology 286
- Pharmacology 88
- Cancer Research 61
- Immunology and Allergy 18
- Oncology 72
Countries citing papers authored by Chahrazad Cherifi
This map shows the geographic impact of Chahrazad Cherifi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chahrazad Cherifi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chahrazad Cherifi more than expected).
Fields of papers citing papers by Chahrazad Cherifi
This network shows the impact of papers produced by Chahrazad Cherifi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chahrazad Cherifi. The network helps show where Chahrazad Cherifi may publish in the future.
Co-authors
The 25 scholars most cited alongside Chahrazad Cherifi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis Hit paper breakdown → | 2016 | 296 |
| 2 | 2021 | 62 | |
| 3 | 2023 | 36 | |
| 4 | 2021 | 28 | |
| 5 | 2019 | 24 | |
| 6 | 2021 | 18 | |
| 7 | 2016 | 8 | |
| 8 | 2021 | 8 | |
| 9 | 2024 | 6 | |
| 10 | 2016 | 5 | |
| 11 | 2023 | 1 | |
| 12 | 2018 | 0 |
About Chahrazad Cherifi
Chahrazad Cherifi is a scholar working on Rheumatology, Immunology, Pharmacology, Molecular Biology and Orthodontics, having authored 12 papers that have together received 492 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (5 papers), Inflammatory mediators and NSAID effects (2 papers), Sphingolipid Metabolism and Signaling (1 paper), Complement system in diseases (1 paper), Dental materials and restorations (1 paper), Spondyloarthritis Studies and Treatments (1 paper), TGF-β signaling in diseases (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Rheumatology (286 citations), Pharmacology (88 citations), Cancer Research (61 citations), Immunology and Allergy (18 citations) and Oncology (72 citations). Chahrazad Cherifi has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Martine Esther Cohen-Solal, Eric Haÿ, Pascal Richette, Hang‐Korng Ea, Augustin Latourte, Jérémy Maillet, Wafa Bouaziz, Thomas Funck‐Brentano, Silvia Monteagudo and Rik Jozef Urbain Lories. Their work appears in journals such as Osteoarthritis and Cartilage, Annals of the Rheumatic Diseases, Bone, International Journal of Molecular Sciences and Advanced Materials Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.